Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.

作者: Christopher R. Frei , Marcos I. Restrepo , Eric M. Mortensen , David S. Burgess

DOI: 10.1016/J.AMJMED.2006.02.014

关键词:

摘要: Abstract Purpose We evaluated the impact of guideline-concordant empiric antibiotic therapy on time to clinical stability, switch therapy, length hospital stay, and mortality among patients with community-acquired pneumonia. Methods This is a retrospective cohort study all adult pneumonia managed at 5 community hospitals from November 1, 1999 April 30, 2000. Patients were stratified into discordant groups as defined by 2001 American Thoracic Society 2003 Infectious Diseases America guidelines. Time in-hospital in per-protocol intention-to-treat stepwise regression models that included outcome dependent variable, independent Pneumonia Severity Index score covariate. Results Of 631 evaluable patients, 357 (57%) received therapy. Groups similar respect age, sex, comorbidities, severity illness, processes care. Guideline-concordant was associated significant decrease (P ≤.01), stay (P = .04) for both analyses. In addition, stability analysis only (P = .03). Conclusions Among hospitalized improved survival shorter stay.

参考文章(30)
Eric M Mortensen, Marcos I Restrepo, Antonio Anzueto, Jacqueline Pugh, The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia Critical Care. ,vol. 10, pp. 1- 8 ,(2005) , 10.1186/CC3934
Christopher R. Frei, Jim M. Koeller, David S. Burgess, Robert L. Talbert, Michael T. Johnsrud, Impact of Atypical Coverage for Patients with Community-Acquired Pneumonia Managed on the Medical Ward: Results from the United States Community-Acquired Pneumonia Project Pharmacotherapy. ,vol. 23, pp. 1167- 1174 ,(2003) , 10.1592/PHCO.23.10.1167.32764
James D. Heffelfinger, Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance Archives of Internal Medicine. ,vol. 160, pp. 1399- 1408 ,(2000) , 10.1001/ARCHINTE.160.10.1399
Eric M. Mortensen, Marcos Restrepo, Antonio Anzueto, Jacqueline Pugh, Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. The American Journal of Medicine. ,vol. 117, pp. 726- 731 ,(2004) , 10.1016/J.AMJMED.2004.06.028
Michael S. Niederman, John B. Bass, G. Douglas Campbell, Alan M. Fein, Ronald F. Grossman, Lionel A. Mandell, Thomas J. Marrie, George A. Sarosi, Antonio Torres, Victor L. Yu, Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial Therapy The American review of respiratory disease. ,vol. 148, pp. 1418- 1426 ,(1993) , 10.1164/AJRCCM/148.5.1418
Derek C. Angus, Thomas J. Marrie, D. Scott Obrosky, Gilles Clermont, Tony T. Dremsizov, Christopher Coley, Michael J. Fine, Daniel E. Singer, Wishwa N. Kapoor, Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. American Journal of Respiratory and Critical Care Medicine. ,vol. 166, pp. 717- 723 ,(2002) , 10.1164/RCCM.2102084
Ethan A. Halm, Michael J. Fine, Thomas J. Marrie, Christopher M. Coley, Wishwa N. Kapoor, D. Scott Obrosky, Daniel E. Singer, Time to Clinical Stability in Patients Hospitalized With Community-Acquired Pneumonia Implications for Practice Guidelines JAMA. ,vol. 279, pp. 1452- 1457 ,(1998) , 10.1001/JAMA.279.18.1452